Geron Corporation, a pioneering biotechnology firm headquartered in the United States, focuses on developing innovative therapies for cancer and other serious diseases. Founded in 1990, Geron has made significant strides in the field of telomerase biology, positioning itself as a leader in the development of telomerase inhibitors. The company’s flagship product, imetelstat, is a first-in-class telomerase inhibitor that targets cancer stem cells, offering a unique approach to treating various malignancies. Geron’s commitment to advancing cancer treatment has garnered attention within the industry, as it continues to explore new therapeutic avenues and expand its operational reach. With a strong emphasis on research and development, Geron Corporation remains at the forefront of biopharmaceutical innovation, striving to improve patient outcomes in oncology.
How does Geron Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Geron Corporation's score of 25 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Geron Corporation, headquartered in the US, currently does not have available carbon emissions data for the most recent year, as indicated by the absence of specific figures. Consequently, there are no reported emissions in terms of Scope 1, 2, or 3 emissions, nor are there any documented reduction targets or achievements. The company has not outlined any specific climate commitments or initiatives, such as Science-Based Targets (SBTi) or other industry-standard climate pledges. As a result, Geron Corporation's current climate strategy and emissions management remain unclear. In the context of the industry, it is essential for companies like Geron to establish measurable climate commitments and reduction targets to align with global sustainability goals. Without such data, stakeholders may find it challenging to assess the company's environmental impact and commitment to climate action.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Geron Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.